Sign in if you already have an account.
         
donate.gif

National Spotlight

Who are you running for? — Join in the fight against breast cancer by running a full or half marathon through Marathon for the Cure™

Rally for the Cure — Golf, tennis, dinner events and so much more...

A brand to trust — We are honored that Susan G. Komen for the Cure® ranked number one in a recent Harris Interactive poll as the most valued non-profit brand and the charity people are most likely to donate money to. Additionally, Komen for the Cure ranked second on the 2010 list of the nation’s most trusted charities. Thank you to all who help us daily in the fight to end breast cancer!

Research Programs

Did you know that every major advance in the fight against breast cancer has been touched by Susan G. Komen for the Cure®?  That we've provided more money for breast cancer research and community health programs than any entity besides the U.S. government?  Komen for the Cure's goal is to "energize science to find the cures."

Komen’s commitment to supporting life-saving research has never been stronger.  Building on 27 years of funding research to find the causes and cures of breast cancer, Komen continues its important new focus on research that will speed the translation of discoveries into reductions in breast cancer mortality and/or incidence within the next decade and on addressing disparities in breast cancer across populations.

A minimum of 25 percent of the net income from each domestic Affiliate supports the Komen for the Cure Grant Program, which funds groundbreaking breast cancer research, meritorious awards and educational and scientific conferences around the world.

Information about National Research Programs

We have made a promise to end breast cancer forever – energizing science to find the cures is a critical part of this promise.   Click here to read more about some that are fulfilling this promise.

Co-funding North Carolina Research Grant

The Charlotte Affiliate is excited to co-fund the following Komen peer reviewed research selected for funding by the Scientific Advisory Board and approved by the Komen Board of Directors:

Breast Cancer in African American Women: DNA Methylation Studies in Basal-like, HER2+,
and Luminal A and B Subtypes

Theresa Swift-Scanlan, PhD, University of North Carolina at Chapel Hill Chapel Hill, NC
Scientific Area: Diagnostic and Prognostic Biomarkers